Adefovir (CAS 106941-25-7): A Key Antiviral Pharmaceutical Intermediate

Discover Adefovir, a critical fine chemical and pharmaceutical intermediate vital for antiviral drug development. Learn about its applications, specifications, and reliable sourcing from NINGBO INNO PHARMCHEM CO.,LTD., your trusted manufacturer and supplier in China.

Get a Quote & Sample

Why Choose Our Adefovir?

Quality Assurance

We guarantee the purity and consistency of our Adefovir (CAS 106941-25-7), meeting stringent pharmaceutical standards. As a dedicated supplier, we ensure each batch adheres to critical specifications for your research and production needs.

Reliable Supply Chain

Procure Adefovir with confidence. Our robust manufacturing capabilities in China ensure a stable and consistent supply, making us a dependable partner for your ongoing projects and bulk purchase requirements.

Competitive Pricing

NINGBO INNO PHARMCHEM CO.,LTD. offers competitive pricing for Adefovir (CAS 106941-25-7), providing cost-effective solutions for pharmaceutical companies and research institutions. Request a quote for the best price on bulk orders.

Key Applications of Adefovir

Antiviral Therapies

Adefovir is a critical component in the synthesis of antiviral medications, specifically targeting viruses like Hepatitis B and Herpes Simplex Virus. As a key pharmaceutical intermediate, it plays a vital role in drug formulation.

Pharmaceutical Research & Development

Researchers and product formulators utilize Adefovir for its known antiviral properties in various stages of drug discovery and development. Enquire about purchasing for your R&D projects.

Chemical Synthesis

As a fine chemical, Adefovir serves as a valuable building block in complex organic synthesis pathways, enabling the creation of novel compounds for pharmaceutical applications.

Hepatitis B Treatment Manufacturing

We are a direct manufacturer of Adefovir, supporting the large-scale production of treatments for Hepatitis B. Contact us to discuss bulk supply and manufacturing partnerships.